Rani Therapeutics Expands Oral Biologics Push With Obesity, Immunology PipelineMarket Beat·1 day ago, 03:01 PMRANI-0.03%CHGCY-0.46%
Lexaria Bioscience Stock Rallies Thursday: What Investors Need to Knowbenzinga_article·Aug 13 at 02:18 PMLEXX+14.16%02565-3.07%
Lexaria signs material transfer agreement with PegBio to test DehydraTECH with GLP-1 moleculePUBT·Aug 13 at 08:00 AMLEXX+14.16%02565-3.07%
Rani Therapeutics Maintained at Buy as Partnerships Highlight Underappreciated Pipeline; $11 Price Target ReaffirmedTip Ranks·Jul 13 at 10:35 AMRANI-0.03%4519
Hong Kong Stock Movement: PEGBIO CO-B falls 10.10%, positive cooperation fails to mask profit concernsHK Stock Alerts·Jul 13 at 02:36 AM02565-3.07%
Hong Kong Stock Movement: PEGBIO CO-B surged 27.49%, partnering with Rani Therapeutics to expand its global GLP-1 layoutHK Stock Alerts·Jul 9 at 09:02 PM02565-3.07%
Hong Kong Stock Movement: PEGBIO CO-B rises 16.82%, deepening international cooperation boosts market confidenceHK Stock Alerts·Jul 9 at 08:37 PM02565-3.07%
PegBio Teams with Rani Therapeutics to Pursue Oral Metabolic TherapiesTip Ranks·Jul 9 at 07:07 PM02565-3.07%RANI-0.03%
Rani Therapeutics partners with PegBio to develop oral obesity drug candidatesPUBT·Jul 9 at 03:11 PMRANI-0.03%02565-3.07%
